On Demand

The Next Frontier of the Life Sciences


Mike Rea

IDEA Pharma

Peyton Howell

Chief Operating and Growth Officer



BioPharma Dive and PharmaVoice are partnering to host a two-day virtual event — The Next Frontier of the Life Sciences — that will examine the top trends shaping the drug industry.

Hosted by our teams of award-winning journalists, the event will bring together newsmaking leaders from across pharma and biotech for thought-provoking keynote presentations, panels and fireside chats. Plus, the beloved PharmaVoice 100 honoree program is back, recognizing the standout leaders of the year.

Who should attend this event? 
Pharma and biotech professionals, researchers, investors and other industry insiders will find a range of valuable takeaways from our two-day, multi-session event.

Attendees will hear unique keynote presentations and can interact with peers during our engaging panel sessions. Our breakout tracks will provide a focused look at genetic medicine, biotech startups, resurgent therapeutic areas and pharmaceutical commercialization.

Session Information
Full information will become available on our Agenda site, or review our session summaries below.

Event Powered by:


Watch Now

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Session Information

Day 1: Wed., October 25th 1pm - 3:30pm EDT

1pm Featured keynote — Fostering breakthrough science: Innovation is the backbone of biotech. In this keynote, our industry leader will discuss what it takes to create an innovative culture and how companies can turn scientific breakthroughs into a pipeline that goes the distance.

1:25pm Panel discussion: After our keynote, join C-suite leaders from the industry who will discuss the state of innovation and how to “future proof” your pipeline.

Next, attendees can choose from the following concurrent sessions:
Track 1 - 2:10pm - 3:30pm - Building a biotech startup: Young biotech companies must contend with a down market that’s all but closed the IPO window. In our first discussion, hear about the steps some are taking to overcome this challenge, and how it is changing venture firms’ approach to funding promising research. Then, biotech executives and investors will share lessons learned from this challenging environment in our second session.
Track 2 - 2:10pm - 3:30pm - Genetic medicine: This year could bring the first approval of a CRISPR medicine. Behind it is an ever-growing pipeline of therapies with many twists on gene editing. In Session 1, get an understanding of what’s next for the field, followed by our second session covering what it will actually take to get these drugs to patients.

Day 2: Thu., October 26th, 1pm - 4:30pm EDT

1pm Featured keynote — The patient of the future: From wearable devices to interactive apps, the patient experience is becoming more digital and streamlined than ever before — especially in the realm of clinical trials. This keynote will zoom in on this rapidly evolving landscape and what it means for how pharma tests and develops drugs.

1:25pm Panel discussion: Hear from clinical trial pros who will explain how technology is transforming the space and what the future holds.

Next, attendees can choose from the following concurrent sessions:
Track 1 - 2:10pm - 3:40pm - Research hot spots: New Alzheimer’s and ALS drugs have put neuroscience research back in focus, while Ozempic and Wegovy sparked an industry gold rush for the next weight loss treatment. Join these two back-to-back sessions to learn what’s driving these fields forward.

Track 2 - 2:10pm - 3:40pm - Commercialization: As emerging technologies transform drug commercialization, it’s an opportune time for companies to explore their plans for launch. In our first session, industry pros will discuss the marketing strategies to keep, and the strategies to ditch, followed by a discussion on how the evolution in patient access will impact orphan drugs.

Thurs, October 26th at 3:40pm - 4:30 EDT
PharmaVoice 100 Celebration and Red Jacket announcement

We will conclude this exciting two-day virtual event by celebrating this year’s PharmaVoice 100.

From 3:40pm-3:50pm EDT, we will salute all of this year’s honorees. Then at 3:50pm we will announce the 2023 Red Jacket winners  — our PharmaVoice 100 “hall of fame.”

To cap it all off, we will host a sit-down discussion starting at 4pm with some of this year’s Red Jacket winners on the key issues facing the industry today.

Looking for the full agenda? Click here for even more details.